The primary objective is to compare the failure rate due to splenic bleeding between the patients undergoing pre-emptive splenic arterial embolization (SAE) as part of non-operative management (NOM) and the patients not undergoing SAE. We hypothesize that the use of pre-emptive SAE will decrease the delayed bleeding rate and increase the success rate of NOM.
This randomised controlled study will follow the clinical course of hemodynamically normal trauma patients with Organ Injury Scale (OIS) grade 4 or 5 blunt splenic injuries, undergoing SAE or observation only until day 7 post injury. Only hemodynamically normal patients will be considered for enrolment into the study, and written informed consent from the patient is required. CONTROL The control arm in this randomized controlled trial will include only NOM patients diagnosed with splenic injuries OIS grade 4 or 5 and suitable for observation alone, and will comprise clinical observation according to local routines and protocols. The patients will be observed with special focus on delayed bleeding and failure of NOM. A contrast enhanced US or CT scan with arterial phase will be performed on day 3-5 to exclude PSA. On day 7, the decision to perform SAE, splenectomy or continue NOM is left to the discretion of each participating institution, and registered in the case report form (CRF). INTERVENTION The intervention arm will perform SAE as a central embolization of the splenic artery. Additional peripheral embolization is left to the discretion of the interventional radiologist. Each institution decides whether patients in the SAE group are to undergo immunization or not. The study does not interfere with local diagnostic work-up and treatment protocols. We hypothesize that the use of pre-emptive SAE will decrease the delayed bleeding rate and increase the success rate of NOM leading to fewer splenectomies in this group of patients without concomitant increased complication rates. Additionally, we want to explore the effects of pre-emptive SAE vs observation alone on all cause failure rate, operative procedures, repeat angiography rate, complications, critical care stay, and mortality.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
224
The intervention arm will perform SAE as a central embolization of the splenic artery. Additional peripheral embolization is left to the discretion of the interventional radiologist.
Denver Health Medical Center
Denver, Colorado, United States
NOT_YET_RECRUITINGUniversity of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
NOT_YET_RECRUITINGFailure of NOM
The primary objective is to compare the failure rate due to splenic bleeding between the patients undergoing pre-emptive SAE as part of NOM and the patients not undergoing SAE. The primary endpoint is the proportion of subjects failing NOM due to spleen related bleeding within 7 days of injury. All analyses will be based on an intention to treat analysis.
Time frame: 7 days
Delayed bleeding episode
Incidence. Delayed bleeding episode is defined as hemodynamically unstable patient, CT verified contrast blush or drop in hemoglobin/hematocrit.
Time frame: 6-12 weeks
All cause and spleen related mortality
Incidence
Time frame: 6-12 weeks
All cause and spleen related failure of NOM
Incidence
Time frame: 6-12 weeks
Pseudoaneurysms (PSA)
Incidence
Time frame: 6-12 weeks
Symptomatic thromboembolic events
Incidence
Time frame: 6-12 weeks
Other spleen related complications
Incidence
Time frame: 6-12 weeks
Angiography related complications
Incidence
Time frame: 6-12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Harborview Medical Center
Seattle, Washington, United States
NOT_YET_RECRUITINGLiverpool Hospital
Sydney, Australia
NOT_YET_RECRUITINGMcGill University Health Centre
Montreal, Canada
NOT_YET_RECRUITINGRigshospitalet
Copenhagen, Denmark
NOT_YET_RECRUITINGKliniken der Stadt Köln
Cologne, Germany
NOT_YET_RECRUITINGUniversity Medical Center
Utrecht, Netherlands
NOT_YET_RECRUITINGOslo Universtity Hospital
Oslo, Norway
RECRUITINGKarolinska Institute
Stockholm, Sweden
NOT_YET_RECRUITING...and 2 more locations